Princeton Conference XXVIII—Cincinnati, Ohio
The 28th Princeton Conference was held in Cincinnati, OH from May 17 to 19, 2012. This conference focused on new advances in research in the field of cerebrovascular disease, and included representatives from academia, industry, and the National Institutes of Health. The Conference was designed as a symposium with crystallized, brief presentations as a stimulus for longer participant discussion. The invited speakers presented new and sometimes unpublished data, as well as ongoing controversies. Topics ranged from the concept of equipoise in clinical trials to the most groundbreaking recent research in the laboratory. Talented junior investigators presented their best ongoing research at a poster session, which was voted on by senior judges. The 2 winners presented their data on the last day of the conference, which are included in the current proceedings. The proceedings of these talks and the subsequent discussions are summarized in this supplement.
The Princeton Conference was first held in 1954 and was initially conceived as a forum to bring together leaders in the field of stroke research to review current scientific work and formulate new directions in research and therapies. The tradition has continued with a biennial meeting. The diversity of participants in this Conference allows for cross-fertilization between basic and clinical scientists as well as senior and more junior investigators. The Conference permits reflection on the current state of the field, unanswered but critical questions, and potential future directions for research.
Publishing the proceedings in Stroke expands the impact of the Conference through peer review and dissemination to all Stroke subscribers, rather than just the conference attendees. On behalf of the Princeton Conference organizers and attendees, we hope that you enjoy reflecting and discussing the proceedings with your colleagues.
We acknowledge the Conference Organizers: Joseph Broderick, Dawn Kleindorfer, Joseph Clark, Barb Forney, Christine Garrett, Sarah Gramann, Neil Holsing, Kathy Nullmeier, Angela Schoner, Susan Tyler, Erin Walker, and Gina Weitzel; Scientific Program Committee: Greg Albers, Joseph Broderick, Joseph Clark, Karen Furie, James Grotta, Thomas Jacobs, Dawn Kleindorfer, Walter Koroshetz; Local Advisory Committee: Joseph Broderick, Dawn Kleindorfer, Joseph Clark, Sarah Gramann, Neil Holsing, Kathy Nullmeier, Angela Schoner, Gina Weitzel; and Conference Sponsors: National Institute of Neurological Disorders and Stroke, UC Health, Ev3-Covidien, Genentech, Concentric Stryker, In Touch Health, Microvention, Codman, and Penumbra.
- Received March 27, 2013.
- Accepted March 28, 2013.
- © 2013 American Heart Association, Inc.